A reduced SMARCA5 level was shown to correlate with anunfavorable prognosis in patients with glioblastoma[60].Overexpression of SMARCA5 contributes to reducedmigration of U87MG cells. This evidence concerns the gene SMARCA5 and glioblastoma.